These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents. Wu X; Kuruba R; Reddy DS J Pharmacol Exp Ther; 2018 Nov; 367(2):302-321. PubMed ID: 30115757 [TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Organophosphate Model of Benzodiazepine-Refractory Status Epilepticus and Neuronal Damage. Singh T; Ramakrishnan S; Wu X; Reddy DS J Pharmacol Exp Ther; 2024 Jan; 388(2):313-324. PubMed ID: 37770202 [TBL] [Abstract][Full Text] [Related]
5. Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman. Reddy DS; Zaayman M; Kuruba R; Wu X Neuropharmacology; 2021 Jun; 191():108571. PubMed ID: 33878303 [TBL] [Abstract][Full Text] [Related]
6. A longitudinal MRI and TSPO PET-based investigation of brain region-specific neuroprotection by diazepam versus midazolam following organophosphate-induced seizures. Hobson BA; Rowland DJ; Dou Y; Saito N; Harmany ZT; Bruun DA; Harvey DJ; Chaudhari AJ; Garbow JR; Lein PJ Neuropharmacology; 2024 Jun; 251():109918. PubMed ID: 38527652 [TBL] [Abstract][Full Text] [Related]
7. Delayed Adjunctive Treatment of Organophosphate-Induced Status Epilepticus in Rats with Phenobarbital, Memantine, or Dexmedetomidine. Spampanato J; Bealer SL; Smolik M; Dudek FE J Pharmacol Exp Ther; 2020 Oct; 375(1):59-68. PubMed ID: 32873622 [TBL] [Abstract][Full Text] [Related]
8. Validating a model of benzodiazepine refractory nerve agent-induced status epilepticus by evaluating the anticonvulsant and neuroprotective effects of scopolamine, memantine, and phenobarbital. Jackson C; Ardinger C; Winter KM; McDonough JH; McCarren HS J Pharmacol Toxicol Methods; 2019; 97():1-12. PubMed ID: 30790623 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotectant Activity of Novel Water-Soluble Synthetic Neurosteroids on Organophosphate Intoxication and Status Epilepticus-Induced Long-Term Neurological Dysfunction, Neurodegeneration, and Neuroinflammation. Reddy DS; Singh T; Ramakrishnan S; Huber M; Wu X J Pharmacol Exp Ther; 2024 Jan; 388(2):399-415. PubMed ID: 38071567 [TBL] [Abstract][Full Text] [Related]
10. A Pediatric Rat Model of Organophosphate-Induced Refractory Status Epilepticus: Characterization of Long-Term Epileptic Seizure Activity, Neurologic Dysfunction and Neurodegeneration. Singh T; Ramakrishnan S; Wu X; Reddy DS J Pharmacol Exp Ther; 2024 Jan; 388(2):416-431. PubMed ID: 37977810 [TBL] [Abstract][Full Text] [Related]
11. Comparison of neuropathology in rats following status epilepticus induced by diisopropylfluorophosphate and soman. Rojas A; McCarren HS; Wang J; Wang W; Abreu-Melon J; Wang S; McDonough JH; Dingledine R Neurotoxicology; 2021 Mar; 83():14-27. PubMed ID: 33352274 [TBL] [Abstract][Full Text] [Related]
12. Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats. Lumley LA; Marrero-Rosado B; Rossetti F; Schultz CR; Stone MF; Niquet J; Wasterlain CG Epilepsia Open; 2021 Dec; 6(4):757-769. PubMed ID: 34657398 [TBL] [Abstract][Full Text] [Related]
13. A rodent model of human organophosphate exposure producing status epilepticus and neuropathology. Pouliot W; Bealer SL; Roach B; Dudek FE Neurotoxicology; 2016 Sep; 56():196-203. PubMed ID: 27527991 [TBL] [Abstract][Full Text] [Related]
14. Urethane attenuates early neuropathology of diisopropylfluorophosphate-induced status epilepticus in rats. Rojas A; Wang J; Glover A; Dingledine R Neurobiol Dis; 2020 Jul; 140():104863. PubMed ID: 32283202 [TBL] [Abstract][Full Text] [Related]
15. Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage. Kadriu B; Guidotti A; Costa E; Auta J Toxicology; 2009 Feb; 256(3):164-74. PubMed ID: 19111886 [TBL] [Abstract][Full Text] [Related]
16. Antiseizure and neuroprotective effects of delayed treatment with midazolam in a rodent model of organophosphate exposure. Spampanato J; Pouliot W; Bealer SL; Roach B; Dudek FE Epilepsia; 2019 Jul; 60(7):1387-1398. PubMed ID: 31125451 [TBL] [Abstract][Full Text] [Related]
17. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. McTague A; Martland T; Appleton R Cochrane Database Syst Rev; 2018 Jan; 1(1):CD001905. PubMed ID: 29320603 [TBL] [Abstract][Full Text] [Related]
18. The K Barker BS; Spampanato J; McCarren HS; Berger K; Jackson CE; Yeung DT; Dudek FE; McDonough JH Neuroscience; 2021 May; 463():143-158. PubMed ID: 33836243 [TBL] [Abstract][Full Text] [Related]
19. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage. White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444 [TBL] [Abstract][Full Text] [Related]
20. Midazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisal. Reddy SD; Reddy DS Epilepsia; 2015 Jun; 56(6):813-21. PubMed ID: 26032507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]